Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
4.810
-0.010 (-0.21%)
At close: Feb 21, 2025, 4:00 PM
4.700
-0.110 (-2.29%)
After-hours: Feb 21, 2025, 4:30 PM EST
Genelux Employees
Genelux had 23 employees as of December 31, 2023. The number of employees increased by 8 or 53.33% compared to the previous year.
Employees
23
Change (1Y)
8
Growth (1Y)
53.33%
Revenue / Employee
$348
Profits / Employee
-$1,202,609
Market Cap
164.04M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 23 | 8 | 53.33% |
| Dec 31, 2022 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
GNLX News
- 19 days ago - Genelux Corporation Announces New Chief Financial Officer - GlobeNewsWire
- 2 months ago - Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright - GlobeNewsWire
- 3 months ago - Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference - GlobeNewsWire
- 4 months ago - Genelux: 2nd Half Of 2025 PRROC Data Is Major Inflection Point - Seeking Alpha
- 4 months ago - Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer - GlobeNewsWire
- 4 months ago - Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 6 months ago - Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 6 months ago - Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates - GlobeNewsWire